UOBScholar Hub
UOB Libraries created the UOBScholar Hub, an Institutional Repository (IR) for archiving and collecting all the research output of the UOB community. It aims to improve the visibility, usage and impact of research conducted at UOB. Materials included are: academic journal articles, conference papers and presentations, books and book chapters, ongoing research papers, reports and patents.
Submit your Publication
Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/5219| Title: | Abemaciclib, a third CDK 4/6 inhibitor for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer | Authors: | El Hachem, Georges Gombos, Andrea Awada, Ahmad |
Affiliations: | Faculty of Medicine | Keywords: | CDK 4/6 inhibitors Luminal breast cancer Abemaciclib Brain metastases Hormone receptor positive |
Issue Date: | 2021 | Publisher: | Taylor & Francis Online | Part of: | Expert Review of Anticancer Therapy | Volume: | 21 | Issue: | 1 | Start page: | 81 | End page: | 92 | Abstract: | The field of metastatic luminal breast cancer (hormone receptor positive, HER-2 negative) is dynamic and evolving, harboring some of the most significant therapeutic advances in medical oncology. Over the last decade, many pivotal trials showed excellent results with drastic improvements in survival as well as the quality of life of metastatic luminal breast cancer patients. |
URI: | https://scholarhub.balamand.edu.lb/handle/uob/5219 | ISSN: | 14737140 | DOI: | 10.1080/14737140.2020.1834385 | Ezproxy URL: | Link to full text | Type: | Journal Article |
| Appears in Collections: | Faculty of Medicine |
Show full item record
SCOPUSTM
Citations
8
checked on Nov 16, 2024
Record view(s)
71
checked on Nov 22, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.